Company: IONQ
Filing Date: 2025-02-27
Form Type: 424B5
Source: 0001193125-25-037295
Chunk: 0

Company: IonQ, Inc.
Filing Date: 2025-02-27
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-285279 PROSPECTUS SUPPLEMENT (To Prospectus dated February 26, 2025) Up to $500,000,000 Common Stock We have entered into an equity distribution agreement (the “equity distribution agreement”) with Morgan Stanley & Co. LLC (“Morgan Stanley”) and Needham & Company, LLC (“Needham”) relating to the sale of shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. We refer to each of Morgan Stanley and Needham as a “sales agent” and collectively as the “sales agents.” In accordance with the terms of the equity distribution agreement, under this prospectus supplement and the accompanying prospectus, we may offer and sell shares of our common stock, having an aggregate offering price of up to $500.0 million from time to time through or to any sales agent. Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “IONQ.” On February 25, 2025, the last reported sale price of our common stock on the NYSE was $29.73 per share. Sales of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions, including block trades, or transactions that are deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), including sales made by means of ordinary brokers’ transactions, including directly on the NYSE or sales made to or through a market maker other than on an exchange at prevailing market prices, at prices related to prevailing market prices or at negotiated prices or by any other methods permitted by law. Subject to the terms of the equity distribution agreement, the sales agents are not required to sell any specific number or dollar amount of securities, but will act as our sales agents using commercially reasonable efforts consistent with their normal trading and sales practices, on mutually agreed terms between the sales agents and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement. The sales agents will be entitled to compensation at a commission rate of up to 3.25% of the gross proceeds of any shares of our common stock sold under the equity distribution agreement. In connection with the sale of our common stock